Development of novel adenosine receptor ligands based on the 3-amidocoumarin scaffold-Reference-Cited by-同舟云学术

Development of novel adenosine receptor ligands based on the 3-amidocoumarin scaffold

Published:2015-08 Issue: Volume:61 Page:1-6
ISSN:0045-2068
Container-title:Bioorganic Chemistry
language:en
Short-container-title:Bioorganic Chemistry

Author:

Matos Maria J.,Vilar Santiago,Kachler Sonja,Celeiro Maria,Vazquez-Rodriguez Saleta,Santana Lourdes,Uriarte Eugenio,Hripcsak George,Borges Fernanda,Klotz Karl-Norbert

Funder

Fundação para a Ciência e Tecnologia

POPH

QREN

Universidade do Porto

Plan Galego de Investigación

Innovación e Crecemento 2011–2015

European Social Fund

Angeles Alvariño Program

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Molecular Biology,Biochemistry

Reference33 articles.

1. Mechanisms of induction of adenosine receptor genes and its functional significance

2. Adenosine Receptor Antagonists: Translating Medicinal Chemistry and Pharmacology into Clinical Utility

3. Adenosine receptors: therapeutic aspects for inflammatory and immune diseases

4. Investigational A3adenosine receptor targeting agents

5. Progress towards novel adenosine receptor therapeutics gleaned from the recent patent literature

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The synthesis, biological evaluation, and fluorescence study of 3-aminocoumarin and their derivatives: a brief review;Monatshefte für Chemie - Chemical Monthly;2023-01

2. Adenosine receptor antagonists: Recent advances and therapeutic perspective;European Journal of Medicinal Chemistry;2022-01

3. Exploration of chalcones and related heterocycle compounds as ligands of adenosine receptors: therapeutics development;Molecular Diversity;2021-06-27

4. Adenosine Receptor Ligands: Coumarin–Chalcone Hybrids as Modulating Agents on the Activity of hARs;Molecules;2020-09-19

5. Structure-Based Optimization of Coumarin hA3 Adenosine Receptor Antagonists;Journal of Medicinal Chemistry;2019-11-18